Biomarker Selection for Maintenance Therapy in Advanced NSCLC

EGFR mutation is a predictive biomarker for maintenance erlotinib but its clinical application is limited. This podcast will explain why.

Episode metadata supplied by the publisher feed · Published Sep 29, 2011

Embed this episode

Attribution link and audio player

NOW PLAYING

Biomarker Selection for Maintenance Therapy in Advanced NSCLC

0:00 9:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 9 minutes long.

This episode was published on September 29, 2011.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!